Revenues of NIKA PHARMACEUTICALS, INC from 31 Dec 2021 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
NIKA PHARMACEUTICALS, INC annual and quarterly Revenues in USD history and change rate from 31 Dec 2021 to 31 Dec 2024.
  • NIKA PHARMACEUTICALS, INC Revenues for the quarter ending 30 Jun 2024 was $156.
  • NIKA PHARMACEUTICALS, INC annual Revenues for 2024 was $0.
  • NIKA PHARMACEUTICALS, INC annual Revenues for 2023 was $0.
  • NIKA PHARMACEUTICALS, INC annual Revenues for 2022 was $0.
Source SEC data
View on sec.gov
Revenues, Annual (USD)
Revenues, Quarterly (USD)

NIKA PHARMACEUTICALS, INC Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $0 $0 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $0 $0 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2024 2023 FY
2022 $0 $0 01 Jan 2022 31 Dec 2022 10-K 10 Apr 2023 2022 FY
2021 $0 01 Jan 2021 31 Dec 2021 10-K 03 Mar 2022 2021 FY

NIKA PHARMACEUTICALS, INC Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $156 01 Apr 2024 30 Jun 2024 10-Q/A 01 Nov 2024 2024 Q2
Q1 2023 $0 $0 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q1 2022 $0 01 Jan 2022 31 Mar 2022 10-Q 12 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.